Neuroscientific Biopharmaceuticals Ltd. (AU:NSB) has released an update.
Neuroscientific Biopharmaceuticals Ltd. has announced the cessation of 1,175,000 options due to expiry without exercise or conversion on April 6, 2024. This financial update, relevant for investors tracking the company’s capital structure, reflects changes in the securities issued by the firm.
For further insights into AU:NSB stock, check out TipRanks’ Stock Analysis page.
